Eli Lilly commits $85 million upfront and over $1.8 billion in potential milestones to partner with Repertoire Immune Medicines, aiming to develop a new class of 'tolerizing' therapies that reset the immune system without broad suppression.
Two Hasbro investors have filed a federal derivative lawsuit, accusing the company's leadership of deliberately overproducing Magic: The Gathering cards to mask weaknesses in other divisions, a move they claim devalued the collectible game and misled shareholders about its true financial health.
A routine commute in Minneapolis turns into a biometric checkpoint, spotlighting the advanced surveillance tools—from facial recognition apps to vast data networks—now central to federal immigration enforcement. As operations intensify, questions mount over privacy, oversight, and the line between targeted enforcement and dragnet surveillance.
Russian forces are integrating Starlink satellite terminals into their drone fleet, creating a new generation of long-range, jamming-resistant weapons capable of striking deep behind Ukrainian lines and into NATO territory, according to intelligence reports and military analysts.
A U.S. Navy destroyer has docked at Israel's southern port of Eilat, a move reported by Israeli media as U.S.-Iranian tensions simmer. While officials describe the deployment as routine, it coincides with a significant American military buildup in the region.
A provocative art installation in Tokyo, featuring a violently thrashing robot dog restrained by a metal chain, is drawing crowds and forcing viewers to confront uneasy questions about the future of artificial intelligence, ethics, and our emotional connection to machines.
A deep dive into Kadant Inc.'s intrinsic value using a Discounted Cash Flow model suggests the stock is trading near its estimated fair value of $273, raising questions about its near-term upside potential amid current market prices.
Starbucks is overhauling its popular Rewards program for over 35 million U.S. members, introducing a tiered structure (Green, Gold, Reserve) designed to offer faster, more personalized benefits and deeper integration with travel partners.
Amidst market turbulence, European investors are turning to high-yield dividend stocks for income stability. We examine three companies offering compelling payouts, weighing their potential rewards against inherent risks.
Shares of life sciences toolmaker Qiagen (NYSE:QGEN) have shown renewed momentum, gaining over 12% in the past month. This surge brings the company's valuation into sharp focus, with analysts divided between near-term earnings multiples and long-term cash flow projections.
Multiple company directors at the UK hydrogen power specialist have invested heavily in its stock over the past year, a move often interpreted as a bullish signal on future prospects, despite the shares trading significantly higher now.
Uber Technologies is aggressively expanding its autonomous vehicle ecosystem through new partnerships and its AV Labs division, even as a landmark New Jersey court decision threatens to upend its core gig-economy labor model, setting the stage for a pivotal clash between its future vision and present-day regulatory challenges.
Linde plc (LIN) shares have shown consistent upward momentum, closing recently at $455. While short-term performance is strong, a deeper valuation analysis reveals a complex picture, with divergent views on whether the stock is a bargain or fully priced.
Nomura Holdings (TSE:9716) has surged 33% in three months, briefly pausing last week. As shares hover around ¥1,367, analysts debate whether the market has fully priced in the brokerage's recovery or if a significant valuation gap remains.
Summit Therapeutics (SMMT) finds itself at a crossroads, with its stock down over 30% in the past year. Conflicting signals from valuation models paint a complex picture: is the biotech firm dramatically overvalued on traditional metrics, or deeply undervalued based on future cash flows?
Tencent Holdings has received regulatory approval to import Nvidia's advanced H200 AI chips, a significant move that enhances its competitive edge in cloud and AI services while navigating ongoing US technology restrictions.
Federal officials have issued provisional approval to relocate 30 beluga whales and four dolphins from the shuttered Ontario park to accredited U.S. aquariums, averting an immediate euthanasia threat pending final health and care plans.
Tesla is discontinuing its flagship Model S sedan and Model X SUV, a strategic shift underscored by plummeting sales figures and Elon Musk's pivot toward robotics and autonomy.
Foreign women detained in Syria's Roj camp, linked to the Islamic State group, see a potential path to freedom following a government offensive that weakened their Kurdish guards. As political dynamics shift, their hopes for amnesty or repatriation collide with international reluctance and an uncertain future for the camps.
Marsh & McLennan's insurance brokerage giant Marsh reported a 4.2% rise in Q4 net income to $821 million, capping a year of robust growth and strategic brand realignment under the new 'Marsh Risk' banner.
